Direct detection of rifampicin resistant Mycobacterium tuberculosis in sputum by Line Probe Assay (LiPA)

Kekkaku

Volumn 79, Issue 9, 2004, Pages 525-530

  Higuchi, Takeshi ^a   Fushiwaki, Takeshi ^b   Tanaka, Nakako ^b   Miyake, Seigo ^b   Ogura, Takeshi ^b   Yoshida, Hiroko ^c   Takashima, Tetsuya ^c   Nakagawa, Masaru ^d   Maekura, Ryoji ^d   Hiraga, Totu ^d   Suetake, Toshinori ^e  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

^b Osaka Hosp Anti TB Assoc Osaka Br   (Japan)

^c OSAKA GENERAL MEDICAL CENTER   (Japan)

^d TONEYAMA NATIONAL HOSPITAL   (Japan)

^e Nipro Corporation   (Japan)

Author keywords

Line probe assay; Mycobacterium tuberculosis; Rifampicin resistance; rpoB gene; Sputum

Indexed keywords

RIFAMPICIN;

ARTICLE; ASSAY; BACTERIUM DETECTION; DRUG EFFECT; EARLY DIAGNOSIS; GENE; HUMAN; HUMAN CELL; INFECTION CONTROL; LINE PROBE ASSAY; MYCOBACTERIUM TUBERCULOSIS; RPOB GENE; SAMPLING; SPUTUM ANALYSIS; STRAIN DIFFERENCE; TUBERCULOSIS; WILD TYPE;

ANTIBIOTICS, ANTITUBERCULAR; DNA-DIRECTED RNA POLYMERASES; DRUG RESISTANCE, BACTERIAL; HUMANS; IN SITU HYBRIDIZATION; MICROBIAL SENSITIVITY TESTS; MUTATION; MYCOBACTERIUM TUBERCULOSIS; REAGENT KITS, DIAGNOSTIC; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SPUTUM; TUBERCULOSIS, PULMONARY;

EID: 7044239462     PISSN: 00229776     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Zhang Y, Heym B, Allen B, et al.: The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature. 1992; 358: 591-593.
2. Banerjee A, Dubnau E, Quemard A, et al: inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994; 263: 227-230.
3. Goto M, Oka S, Tachikawa N, et al.: katG sequence deletion is not major cause of isoniazid resistance in Japanese and Yemeni Mycobacterium tuberculosis isolates. Mol Cellular Probes. 1995; 9: 433-439.
4. Jin D, Gross CA: Characterization of the pleiotropic phenotypes of rifampin-resistant rpoB mutants of Escherichia coli. J Bacteriol. 1989; 171: 5229-5231.
5. Telenti A, Imboden P, Marchesi F, et al.: Detection of rifampicin-resistant mutations in Mycobacterium tuberculosis. Lancet. 1993; 341: 647-650.
6. Williams DL, Waguespack C, Eisenach K, et al.: Characterization of rifampin resistance in pathogenic mycobacteria. Antimicrob Agents Chemother. 1994; 38: 2380-2386.
7. Suzuki Y, Katsukawa C, Inoue K, et al.: Mutations in rpoB gene of rifampicin resistant clinical isolates of Mycobacterium tuberculosis in Japan. J Jpn Assoc Meet Dis. 1995; 69: 413-419.
8. Taniguchi H, Aramaki H, Nikaido Y, et al.: Rifampicin resistance and mutation of the rpoB gene in Mycobacterium tuberculosis. FEMS Microbiol Lett. 1996; 144: 103-108.
9. Ohno H, Koga H, Kohno S, et al.: Relationship between rifampin MICs and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan. Antimicrob Agents Chemother. 1996; 40: 1053-1056.
10. Scorpio A, Zhang Y: Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the anti-tuberculous drug pyrazinamide in tubercle bacillus. Nat Med. 1996; 2: 662-667.
11. Sreevatsan S, Pan X, Zhang Y, et al.: Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms. Antimicrob Agents Chemother. 1997; 41: 636-641.
12. Hirano K, Takahashi M, Kazumi Y, et al.: Mutation in pncA is a major mechanism of pyrazinamide resistance in Mycobacterium tuberculosis. Tubercle Lung Dis. 1998; 78: 117-122.
13. Finken M, Kirschner P, Meier A, et al.: Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol. 1993; 9: 1239-1246.
14. Katsukawa C, Tamaru A, Miyata Y, et al.: Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan. J Appl Microbiol. 1997; 83: 634-640.
15. Nair J, Rouse DA, Bai G-H, et al.: The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. Mol Microbiol. 1993; 10: 521-527.
16. Belanger AE, Besra GS, Ford ME, et al.: The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol. Proc Natl Acad Sci USA. 1996; 93: 11919-11924.
17. Sreevatsan S, Stochbauer KE, Pan X, et al.: Ethambutol resistance in Mycobacterium tuberculosis: critical role of embB mutations. Antimicrob Agents Chemother. 1997; 41: 1677-1681.
18. Taniguchi H, Chang B, Abe C, et al.: Molecular analysis of kanamycin and viomycin resistance in Mycobacterium smegmatis by use of the conjugation system. J Bacteriol. 1997; 179: 4795-4801.
19. Suzuki Y, Katsukawa C, Tamaru A, et al.: Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol. 1998; 36: 1220-1225.
20. Cambau E, Sougakoff W, Besson M, et al.: Selection of a gyrA mutant of Myconacterium tuberculosis resistant to fluoroquinolones during treatment with ofloxacin. J Infect Dis. 1994; 170: 479-483.
21. Rossau R, Traore H, de Beenhouwer H, et al.: Evaluation of the INNO-LiPA Rif. TB assay, a reverse hybridization assay for the stimulation detection of Mycobacterium tuberculosis complex and its resistance to rifampin. Antimicrob Agents Chemother. 1997; 41: 2093-2098.
22. Hirano K, Abe C, Takahashi M: Mutations in the rpoB gene of rifampin-resistant Mycobacterium tuberculosis strains isolated mostly in Asian countries and their rapid detection by line probe assay. J Clin Microbiol. 1999; 37: 2663-2666.
23. Cooksey RC, Morlock GP, Glichman S, et al.: Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from New York City. J Clin Microbiol. 1997; 35: 1281-1283.
24. Liu Y-C, Huang T-S, Huang W-K: Line probe assay for rapid detection of mutations in the rpoB gene of Mycobacterium tuberculosis. J Formos Med Assoc. 1999; 98: 582-585.
25. Laszlo A, Rahman M, Espinal M, et al.: Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis. 2002; 6: 748-756.
26. Watterson SA, Wilson SM, Yates MD, et al.: Comparison of three molecular assays for rapid detection of rifampin resistance in Mycobacterium tuberculosis. J Clin Microbiol. 1998; 36: 1969-1973.
27. Heym B, Honore N, Truffot-Pernot C, et al.: Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet. 1994; 344: 293-298.
28. Hanna BA, Ebrahimzadeh A, Elliott LB, et al.: Multicenter evaluation of the BACTEC MGIT 960 system for recovery of mycobacteria. J Clin Microbiol. 1999; 37: 748-752.
29. Gamboa F, Cardona PJ, Manterola JM, et al.: Evaluation of a commercial probe assay for detection of rifampin resistance in Mycobacterium tuberculosis directly from respiratory and nonrespiratory clinical samples. Eur J Clin Microbiol Infect Dis. 1998; 17: 189-192.
30. Marttila HJ, Soini H, Vyshnevskaya E, et al.: Line probe assay in the rapid detection of rifampin-resistant Mycobacterium tuberculosis directly from Clinical specimens. Scand J Infect Dis. 1999; 31: 269-273.
31. Johansen IS, Lundgren B, Sosnovskaja A, et al.: Direct detection of multidrug-resistant Mycobacterium tuberculosis in clinical specimens in low- and high-incidence countries by line probe assay. J Clin Microbiol. 2003; 41: 4454-4456.